Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 335 participants.

Also called NCT01235351

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 335 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01235351
Other papers using this trial's data
  • Diabetes mellitus, CYP2C19 genotype, and response to escalating doses of clopidogrel. Insights from the ELEVATE-TIMI 56 Trial Thrombosis and haemostasis, 2016-07-04 DOI, PubMed 27009617
  • Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease JAMA, 2011-11-23 DOI, PubMed 22088980
  • Variability of individual platelet reactivity over time in patients treated with clopidogrel: insights from the ELEVATE-TIMI 56 trial Journal of the American College of Cardiology, 2014-07-29 DOI, PubMed 25060370, PMC11284982 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01235351. Randomized; quadruple masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2011-09 (actual). Results posted on 2019-11-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56
Acronym
ELEVATE
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Clopidogrel
Lead sponsor
The TIMI Study Group (class: other)
Collaborator
Bristol-Myers Squibb (class: industry)
Collaborator
Sanofi (class: industry)

Record details

Record id
cardio:ct-nct01235351
Content hash
24eaf4da389ac0b1c04f8d9b2e0d7b6c41c7ab1cb9b948fd81dded6e2bc78552